Early Breast Cancer Staging and Management

Staging Classification

Stage I breast cancer includes tumors ≤2 cm without lymph node involvement, and Stage IB includes small tumors with micrometastases in lymph nodes, as defined by the American Joint Committee on Cancer 3
Stage II breast cancer includes tumors ≤2 cm with 1-3 positive axillary lymph nodes or tumors 2-5 cm without lymph node involvement, as per the American Joint Committee on Cancer 3, 4
The American College of Surgeons recommends that Stage IIA breast cancer be treated as a distinct entity with a favorable prognosis 4

The National Comprehensive Cancer Network recommends local therapy, including breast-conserving surgery with radiation or mastectomy, for early breast cancer 4
Systemic therapy for early breast cancer is based on tumor biology, including hormone receptor status and HER2 status, as recommended by the American Society of Clinical Oncology 3
For Stage I breast cancer, primary surgery is often the initial approach, and adjuvant paclitaxel plus trastuzumab for 12 weeks may be recommended for small tumors with HER2-positive disease, according to the European Society for Medical Oncology 1
For Stage II breast cancer, breast-conserving surgery and radiation therapy may be used, and neoadjuvant therapy may be considered for certain biological subtypes, as suggested by the American College of Radiology 1, 4

Tumor size significantly impacts prognosis, with larger tumors associated with higher risk of lymph node involvement, as reported by the European Society for Medical Oncology 5
Axillary lymph node status is one of the strongest prognostic indicators in early breast cancer, according to the National Cancer Institute 5
Molecular subtypes significantly influence prognosis and treatment decisions in early breast cancer, as stated by the American Association for Cancer Research 5